Nationwide Fund Advisors’s Filana Therapeutics FLNA Stock Holding History

Nationwide Fund Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,093	Closed	-$54K	–	3351
2015 Q1	$54K	Hold	4,093	–	–	﹤0.01%	3088
2014 Q4	$58K	Hold	4,093	–	–	﹤0.01%	3007
2014 Q3	$112K	Buy	4,093 +87	+2%	+$2.64K	﹤0.01%	2941
2014 Q2	$161K	Buy	+4,006	New	+$148K	﹤0.01%	2847
2013 Q3	–	Sell	-2,425	Closed	-$38K	–	3276
2013 Q2	$38K	Buy	+2,425	New	+$51.3K	﹤0.01%	3003

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's FLNA Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of Filana Therapeutics (FLNA) in Q2 2015, closing a stake of 4,093 shares — an estimated $54K sold.

Nationwide Fund Advisors first reported a position in FLNA in Q2 2013 and held it in 5 quarters. The position peaked at $161K in Q2 2014. 66 funds tracked by Wall St. Rank hold FLNA as of Q2 2015.

Nationwide Fund Advisors reported no remaining Filana Therapeutics position as of Q2 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 4,093 Filana Therapeutics shares in Q2 2015, an estimated $54K.
Nationwide Fund Advisors first reported a position in Filana Therapeutics in Q2 2013 and held it in 5 quarters.
Nationwide Fund Advisors's Filana Therapeutics position peaked at $161K in Q2 2014.
66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.